Stockhub

Arcturus Therapeutics Holdings Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 August 2022

11 August 2022

26 July 2022

  • curprev 18:4918:49, 26 July 2022‎ Chris talk contribs‎ 1,233 bytes +1,233‎ Created page with "Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs in..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Arcturus_Therapeutics_Holdings_Inc.’